Cargando…
Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice
OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharm...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176341/ https://www.ncbi.nlm.nih.gov/pubmed/32188275 http://dx.doi.org/10.1161/ATVBAHA.119.313692 |
_version_ | 1783524999788756992 |
---|---|
author | Perrotta, Paola Van der Veken, Bieke Van Der Veken, Pieter Pintelon, Isabel Roosens, Laurence Adriaenssens, Elias Timmerman, Vincent Guns, Pieter-Jan De Meyer, Guido R.Y. Martinet, Wim |
author_facet | Perrotta, Paola Van der Veken, Bieke Van Der Veken, Pieter Pintelon, Isabel Roosens, Laurence Adriaenssens, Elias Timmerman, Vincent Guns, Pieter-Jan De Meyer, Guido R.Y. Martinet, Wim |
author_sort | Perrotta, Paola |
collection | PubMed |
description | OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharmacological inhibition of glycolytic flux by the small-molecule 3PO (3-[3-pyridinyl]-1-[4-pyridinyl]-2-propen-1-one) could have beneficial effects on plaque formation and composition. APPROACH AND RESULTS: ApoE(−/)(−) (apolipoprotein E deficient) mice treated with 3PO (50 µg/g, ip; 4×/wk, 4 weeks) showed a metabolic switch toward ketone body formation. Treatment of ApoE(−/−)Fbn1(C1039G+/−) mice with 3PO (50 µg/g, ip) either after 4 (preventive, twice/wk, 10 weeks) or 16 weeks of Western diet (curative, 4×/wk, 4 weeks) inhibited intraplaque neovascularization by 50% and 38%, respectively. Plaque formation was significantly reduced in all 3PO-treated animals. This effect was independent of intraplaque neovascularization. In vitro experiments showed that 3PO favors an anti-inflammatory M2 macrophage subtype and suppresses an M1 proinflammatory phenotype. Moreover, 3PO induced autophagy, which in turn impaired NF-κB (nuclear factor-kappa B) signaling and inhibited TNF-α (tumor necrosis factor-alpha)–mediated VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) upregulation. Consistently, a preventive 3PO regimen reduced endothelial VCAM-1 expression in vivo. Furthermore, 3PO improved cardiac function in ApoE(−/−)Fbn1(C1039G+/−) mice after 10 weeks of treatment. CONCLUSIONS: Partial inhibition of glycolysis restrained intraplaque angiogenesis without affecting plaque composition. However, less plaques were formed, which was accompanied by downregulation of endothelial adhesion molecules—an event that depends on autophagy induction. Inhibition of coronary plaque formation by 3PO resulted in an overall improved cardiac function. |
format | Online Article Text |
id | pubmed-7176341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-71763412020-05-04 Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice Perrotta, Paola Van der Veken, Bieke Van Der Veken, Pieter Pintelon, Isabel Roosens, Laurence Adriaenssens, Elias Timmerman, Vincent Guns, Pieter-Jan De Meyer, Guido R.Y. Martinet, Wim Arterioscler Thromb Vasc Biol Basic Sciences OBJECTIVE: Intraplaque neovascularization is an important feature of unstable human atherosclerotic plaques. However, its impact on plaque formation and stability is poorly studied. Because proliferating endothelial cells generate up to 85% of their ATP from glycolysis, we investigated whether pharmacological inhibition of glycolytic flux by the small-molecule 3PO (3-[3-pyridinyl]-1-[4-pyridinyl]-2-propen-1-one) could have beneficial effects on plaque formation and composition. APPROACH AND RESULTS: ApoE(−/)(−) (apolipoprotein E deficient) mice treated with 3PO (50 µg/g, ip; 4×/wk, 4 weeks) showed a metabolic switch toward ketone body formation. Treatment of ApoE(−/−)Fbn1(C1039G+/−) mice with 3PO (50 µg/g, ip) either after 4 (preventive, twice/wk, 10 weeks) or 16 weeks of Western diet (curative, 4×/wk, 4 weeks) inhibited intraplaque neovascularization by 50% and 38%, respectively. Plaque formation was significantly reduced in all 3PO-treated animals. This effect was independent of intraplaque neovascularization. In vitro experiments showed that 3PO favors an anti-inflammatory M2 macrophage subtype and suppresses an M1 proinflammatory phenotype. Moreover, 3PO induced autophagy, which in turn impaired NF-κB (nuclear factor-kappa B) signaling and inhibited TNF-α (tumor necrosis factor-alpha)–mediated VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1 (intercellular adhesion molecule-1) upregulation. Consistently, a preventive 3PO regimen reduced endothelial VCAM-1 expression in vivo. Furthermore, 3PO improved cardiac function in ApoE(−/−)Fbn1(C1039G+/−) mice after 10 weeks of treatment. CONCLUSIONS: Partial inhibition of glycolysis restrained intraplaque angiogenesis without affecting plaque composition. However, less plaques were formed, which was accompanied by downregulation of endothelial adhesion molecules—an event that depends on autophagy induction. Inhibition of coronary plaque formation by 3PO resulted in an overall improved cardiac function. Lippincott Williams & Wilkins 2020-05 2020-03-19 /pmc/articles/PMC7176341/ /pubmed/32188275 http://dx.doi.org/10.1161/ATVBAHA.119.313692 Text en © 2020 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made. |
spellingShingle | Basic Sciences Perrotta, Paola Van der Veken, Bieke Van Der Veken, Pieter Pintelon, Isabel Roosens, Laurence Adriaenssens, Elias Timmerman, Vincent Guns, Pieter-Jan De Meyer, Guido R.Y. Martinet, Wim Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title | Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title_full | Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title_fullStr | Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title_full_unstemmed | Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title_short | Partial Inhibition of Glycolysis Reduces Atherogenesis Independent of Intraplaque Neovascularization in Mice |
title_sort | partial inhibition of glycolysis reduces atherogenesis independent of intraplaque neovascularization in mice |
topic | Basic Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176341/ https://www.ncbi.nlm.nih.gov/pubmed/32188275 http://dx.doi.org/10.1161/ATVBAHA.119.313692 |
work_keys_str_mv | AT perrottapaola partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT vandervekenbieke partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT vandervekenpieter partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT pintelonisabel partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT roosenslaurence partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT adriaenssenselias partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT timmermanvincent partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT gunspieterjan partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT demeyerguidory partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice AT martinetwim partialinhibitionofglycolysisreducesatherogenesisindependentofintraplaqueneovascularizationinmice |